| abstract |
The present invention provides a compound of formula (I): □ pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers thereof, wherein the symbols are as defined herein. The compounds of the invention are useful in the treatment of immune and carcinogenic disorders. |